trans-4-Dimethylaminocrotonic acid hydrochloride CAS NO.848133-35-7
| inoa | trans-4-Dimethylaminocrotonic acid hydrochloride | ||
| CAS NO. | 848133-35-7 | ||
| ʻĀpana Molekala | C6H12ClNO2 | Kaumaha Molecular | 165.62 |
| MDL No. | MFCD03695466 | EINECS | 617-631-8 |
| MP | 162 °C | BP | NA |
| ʻO ka mānoanoa | NA | Hōʻike Hōʻike | NA |
| FP | NA | Kūlana mālama | ʻO ka lewa inert, Ka Mahana lumi |
| Ka nana aku | keʻokeʻo a keʻokeʻo paʻa | ||
| Maemae | 98% | ||
| Palapala noi | Organic synthesis intermediate, Neratinib intermediate, Afatinib intermediate，Trans-4-dimethylaminocroton hydrochloride he reagent no ka hoʻomākaukau ʻana i nā lāʻau antitumor inhibitory tyrosine kinase. | ||
| Hiki ke hoolako | ʻO trans-4-Dimethylaminocrotonic acid hydrochloride CAS NO.848133-35-7 kā mākou huahana hana maʻamau, inā makemake ʻoe i kahi liʻiliʻi liʻiliʻi a i ʻole ka ukana nui i ʻoi aku ma mua o ka tonnage, hiki i kā mākou hui ke hoʻolako maʻamau. | ||
| Inā makemakeʻoe i ka trans-4-Dimethylaminocrotonic acid hydrochloride CAS NO.848133-35-7, eʻoluʻolu e leka uila mai iā mākou, a e hāʻawi mākou iāʻoe i nā huahana maikaʻi loa, ke kumu kūʻai kūpono a me ka lawelawe maikaʻi loa, e kali ana i kā mākou hui. | |
| | |
| Kelepona No. | +86 139 6251 3054 +86 136 2174 3828 |
ʻO nā huahana i heluʻia e ka hui e pili ana i nā patents, kahi wale nō no ka noiʻi a me ka hoʻomohalaʻana aʻaʻole no ke kūʻai aku;e kūʻai ʻia aku nā huahana i hoʻopaʻa ʻia e like me nā kānāwai Kina a me nā kānāwai o ka ʻāina i kūʻai ʻia ai lākou, a ʻaʻole kūpono nā huahana a pau no ka hoʻohana kanaka.Inā kūʻai ʻia, e lilo lākou i ʻāina hōʻino patent, na ka mea kūʻai aku e lawe i nā pilikia pili.
E kākau i kāu leka ma aneʻi a hoʻouna mai iā mākou
![(S)-3-Phenyl-2-[(Pyrazin-2-Ylcarbonyl)Amino] Propanoic Acid CAS NO.114457-94-2](http://cdn.globalso.com/shlzpharma/114457-94-2-1.jpg)
![4-[(4-Methylpiperazin-1-yl)methyl]ʻakika benzoic dihydrochloride CAS NO.106261-49-8](http://cdn.globalso.com/shlzpharma/106261-49-8-1.jpg)
